Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AX Other antihistamines for systemic use
R06AX26 Fexofenadine
D00671 Fexofenadine hydrochloride (JP18/USP) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
44 Allergic agents
449 Miscellaneous
4490 Miscellaneous
D00671 Fexofenadine hydrochloride (JP18/USP)
Classification of Japanese OTC drugs [BR:br08313]
Agents for otolaryngologic use
69 Oral medicine for nasal inflammation
D00671 Fexofenadine hydrochloride (JP18/USP)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Fexofenadine
D00671 Fexofenadine hydrochloride (JP18/USP)
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01117 Fexofenadine
D00671 Fexofenadine hydrochloride
Dermatological agent
DG03243 Atopic dermatitis agent
D00671 Fexofenadine hydrochloride
Drug classes [BR:br08332]
Anti-allergic agent
DG01482 Histamine receptor H1 antagonist
D00671 Fexofenadine hydrochloride
Dermatological agent
DG03243 Atopic dermatitis agent
D00671 Fexofenadine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH1
D00671 Fexofenadine hydrochloride (JP18/USP) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00671 Fexofenadine hydrochloride
D00671 Fexofenadine hydrochloride tablets
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00671
Rx-to-OTC switch list in the USA [br08315.html]
D00671
Rx-to-OTC switch list in Japan [br08314.html]
D00671
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01117 Fexofenadine